Which Gemma 4 Model Should You Actually Use? I Tested All of Them, So You Don't Have To

This is a submission for the Gemma 4 Challenge: Write About Gemma 4

Which Gemma 4 Model Should You Actually Use? I Tested All of them, building a Healthcare AI for African Patients

Most model comparison posts are written by people who read the documentation. This one is written by someone who burned through tokens, hit OOM errors, watched Gemini miss clinical signals it should have caught, and eventually landed on the right answer, but only after eliminating everything else first.

I was building Fisibel, a multimodal African synthetic health data platform. The task: upload a real Nigerian hospital record image, extract clinical signals, and generate privacy-safe synthetic datasets grounded in WHO and World Bank statistics. The model had to read handwritten and printed medical documents, understand African-specific clinical patterns, and generate coherent synthetic data at scale.

Here is what I learned by testing every Gemma 4 option available.

Model	Parameters	Architecture	Best For
Gemma 4 E2B	2B effective	Dense	On-device, mobile, offline
Gemma 4 26B MoE	26B total, 4B active	Mixture-of-Experts	Edge inference, deep reasoning
Gemma 4 31B	31B total	Dense	Maximum quality, unconstrained compute

The architectural difference matters more than the number. Let me explain why.

What Mixture-of-Experts Actually Means in Practice
Most explanations of MoE are theoretical. Here is the practical version.
A dense model activates all its parameters for every token it processes. A 31B dense model is doing 31B parameters of work on every single token — whether that token is "the" or "malaria strain variant specific to Lagos State."
A MoE model routes each token through specialized subnetworks called experts. Only a subset activates per token. Gemma 4 26B MoE has 26B total parameters but activates only ~4B per forward pass.
What this means for you:

Inference speed: closer to a 4B model
Knowledge depth: closer to a 26B model
For specialized tasks: the right experts activate for the right content

That last point is the one that changed my project. When processing clinical documents, MoE routes medical terminology, geographic identifiers, and symptom patterns through subnetworks shaped by that kind of content. A dense model processes a Nigerian hospital record exactly the same way it processes a recipe.

Why I Started With Ollama and Had to Stop
The original Fisibel architecture was local inference via Ollama. If the platform handles real hospital record images, keeping inference local meant zero data leaving the machine. Maximum privacy. No transmission risk.
It did not survive contact with reality.
Downloading Gemma 4 locally through Ollama required pulling a model that was simply too large. In Nigeria, where data costs real money, the download cost alone made the pipeline economically unviable. African healthcare researchers operating in bandwidth-constrained environments cannot build on infrastructure that demands gigabytes just to get started.
Lesson: Local inference is the right privacy instinct. But in bandwidth-constrained environments, the data cost of the initial model download is a real barrier, not an abstract one. If you are building for users outside fibre-connected cities, factor this in before you architect around Ollama.
This pushed the pipeline to Google Cloud — not by preference, but by the economic reality of what local inference actually costs when you are not building from San Francisco.

Why I Rejected Gemma 4 31B
Once on cloud inference, the natural assumption was that bigger meant better. Gemma 4 31B was tested first.
It was not better. It was more expensive for the same output.
For clinical signal extraction specifically — reading a hospital record and pulling out diagnoses, symptoms, treatment patterns, geographic identifiers — the 31B model burned tokens significantly faster without producing meaningfully deeper clinical signals than 26B MoE.
The task does not reward raw parameter count. It rewards specialized reasoning over structured medical text. Paying more tokens for marginal returns on a pipeline that needs to run at scale across African health datasets is not a tradeoff worth making.
When to use 31B: Maximum quality tasks where compute cost is not a constraint. Long-form generation. Complex reasoning chains where you need every parameter engaged. Research environments, not production pipelines running at scale.
When not to use 31B: Specialized extraction tasks. Scale-sensitive pipelines. Anything where you will run the model hundreds or thousands of times.

Why I Tested Gemini and What the Results Actually Showed
Gemini was the obvious alternative. Same multimodal capability, faster inference, Google infrastructure. I tested it directly against Gemma 4 26B MoE on the same Lagos hospital record image.
Gemini was faster. On clinical depth, it lost.
The table below shows clinical signals extracted from the same input document across both models:

Clinical Signal Extracted	Gemma 4 26B MoE	Gemini
Primary diagnosis	✅	✅
Comorbidity pattern	✅	✅
Malaria strain variant	✅	❌
LGA-specific risk factor	✅	❌
Regional treatment protocol	✅	❌
Symptom progression timeline	✅	✅
Geographic disease indicator	✅	❌
Age-adjusted risk signal	✅	✅
Local drug resistance pattern	✅	❌
Nutritional comorbidity flag	✅	❌

Gemini caught the general signals. Gemma 4 26B MoE caught the African-specific ones.
No other model in this size class caught all 6 African-specific signals.
This is not a criticism of Gemini. It is a demonstration of what MoE routing does on specialized content. The signals Gemini missed are not obscure — LGA-specific risk factors and regional treatment protocols are standard clinical identifiers in Nigerian medical documents. The difference is in how each model processes domain-specific terminology.
Speed is not always the metric. For specialized extraction tasks, coverage is.
| Use Case | Recommended Model |
| Mobile / on-device / offline | Gemma 4 E2B |
| Specialized domain extraction at scale | Gemma 4 26B MoE |
| Maximum quality, unconstrained compute | Gemma 4 31B |
| Bandwidth-constrained environments | Gemma 4 26B MoE via cloud |
| Research and fine-tuning experiments | Gemma 4 31B |
| Production pipelines with token cost sensitivity | Gemma 4 26B MoE |

Choose Gemma 4 E2B if:

1. You are building for mobile or on-device
2. Your users have bandwidth or storage constraints
3. You need offline capability after the first setup
4. Your task is classification, routing, or simple generation
5. You are targeting Android phones under $200

Choose Gemma 4 26B MoE if:

1. You need reasoning depth at edge-level inference speed
2. Your task involves specialized domain content — medical, legal, scientific, and regional
3. You are running at scale, and token cost matters
4. You need the best quality-to-cost ratio in production
5. You want MoE expert routing to work in your favour on specialized inputs

Choose Gemma 4 31B if:

1. Compute cost is not a constraint
2. You need maximum quality on complex generation tasks
3. You are doing research, fine-tuning experiments, or one-off analysis
4. Latency is less important than output quality

The One Thing Nobody Tells You About Thinking Mode
Gemma 4 supports thinking traces. I assumed more thinking meant better answers everywhere. That assumption broke two features before I understood what was actually happening.
Thinking mode helps when the model needs to route across multiple options — tool selection, complex reasoning, and ambiguous queries. It hurts when the task is pure structured output composition. With thinking enabled on a structured generation path, the model spends its entire token budget on internal reasoning traces and produces empty or malformed output.
The rule I now follow: thinking ON for routing, thinking OFF for composition. They are different tasks and the model treats them differently.

What This Means for Open Source AI
Gemma 4 26B MoE running on Google Cloud infrastructure, with no proprietary lock-in, matching or exceeding closed models on specialized domain tasks — that is not a minor footnote. That is the story.
For developers building in bandwidth-constrained environments, for researchers working on underrepresented populations, for anyone who needs frontier-level reasoning without frontier-level costs, the gap between open and closed models just got significantly smaller.
The model I needed to see African clinical signals clearly was not the biggest one. It was not the fastest one. It was the one built to route specialized knowledge to the right place.
That turns out to matter more than size.

I built this while developing Fisibel, a multimodal African synthetic health data platform. The clinical signals table above came from real tests on a Lagos hospital record. All findings are from production pipeline decisions, not benchmarks run for this post.